Allurion Technologies Inc. ALUR
Regular-session close
After hours · Nov 18, 4:00 PM ET
- YTD
- -99.84%
- 1 year
- -99.86%
- Market cap
- 1.22K
- Revenue (ttm)
- 34.75M
- Profit margin
- -71.24%
- EPS (ttm)
- -54.75
- Shares out
- 64.80M
- Forward P/E
- -0.93
- YTD return
- -99.84%
- 1-year return
- -99.86%
- Volume
- 2
- Avg volume
- 2.12K
- Open
- 0.55
- Previous close
- 0.002
- Day's range
- 0.55 – 0.55
- 52-week range
- 0.001 – 7.48
- Price target
- 1.83 (+91566.5%)
- 50-day average
- 0.52902
5D 0.00000 (0.00%)
Key statistics
- 200-day average
- 1.15
- Enterprise value
- 71.77M
- Price / sales
- 0.73
- Revenue growth
- -70.50%
- Total cash
- 28.65M
- Total debt
- 77.05M
- Short % of float
- 2.45%
Fundamental scorecard
3 of 25 checks passed on ALUR’s reported financials
3of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 1 of 5
- Dividend 0 of 5
Statements to Sep 30, 2025.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.17 | -0.14 | +0.03 | +17.65% |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | 0.01 | — | — |
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | 0.00 | 0.11 | — | — |
| Mar 21, 2024 | Dec 1, 2023 | -0.51 | -0.63 | -0.12 | -23.53% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | Chardan Capital | down | Buy | Neutral |
| Oct 2, 2024 | TD Cowen | init | — | Buy |
| Sep 6, 2024 | Roth MKM | init | — | Buy |
| Aug 22, 2024 | Chardan Capital | main | Buy | Buy |
| May 15, 2024 | Chardan Capital | main | Buy | Buy |
| Apr 4, 2024 | Chardan Capital | init | — | Buy |
About Allurion Technologies Inc.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- allurion.com
News
Allurion Advances Plan to Re-List
Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum
Allurion Technologies, Inc. (NYSE:ALUR) Short Interest Up 124.0% in February
Allurion Advances Plan to Regain Listing Compliance
Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy
NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)
GN Store Nord (OTCMKTS:GNNDY) and Allurion Technologies (NYSE:ALUR) Financial Survey
Allurion Intends to Appeal NYSE Notice of Delisting, Execute Plan to Regain Compliance, and Expects to Continue Trading on NYSE
NYSE to Commence Delisting Proceedings Against Allurion Technologies, Inc. (ALUR)
Allurion Technologies (NYSE:ALUR) & CeriBell (NASDAQ:CBLL) Head-To-Head Survey
Your note
Sign in to keep a note on ALUR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALBERTI-PEREZ MILENA | Director | Stock Award(Grant) | Mar 10, 2024 | 75,000 |
| BUCH OJAS | Chief Operating Officer | Stock Award(Grant) | Nov 7, 2024 | 306,749 |
| CHARDON BENOIT | Officer | Conversion of Exercise of derivative security | Dec 11, 2023 | 199,183 |
| DAVIN MICHAEL R | Director | Stock Award(Grant) | Oct 22, 2023 | 110,422 |
| GIBBONS BRENDAN M | Officer | Stock Award(Grant) | Nov 7, 2024 | 306,749 |
| GUPTA KRISHNA K. | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Oct 22, 2023 | 5,997,700 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Armistice Capital, LLC | 12.05% | 7,806,000 | 3.04M | Sep 29, 2024 |
| RTW Investments LP | 5.71% | 3,697,549 | 1.44M | Sep 29, 2024 |
| Fortress Investment Group LLC | 1.95% | 1,261,747 | 491.95K | Sep 29, 2024 |
| Unisphere Establishment | 1.92% | 1,242,330 | 484.38K | Sep 29, 2024 |
| Vanguard Group Inc | 1.85% | 1,200,728 | 468.16K | Sep 29, 2024 |
| CVI Holdings, LLC | 0.80% | 521,440 | 203.31K | Jun 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.03% | 667,294 | 260.18K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.78% | 505,196 | 196.97K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.46% | 295,912 | 115.38K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.12% | 75,000 | 29.24K | Sep 29, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 69,979 | 27.28K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.10% | 67,158 | 26.18K | Oct 30, 2024 |
